comparemela.com

Repligen (NASDAQ:RGEN – Get Rating) had its price objective dropped by research analysts at Royal Bank of Canada from $170.00 to $157.00 in a note issued to investors on Wednesday, The Fly reports. Royal Bank of Canada’s price target would suggest a potential downside of 3.20% from the stock’s previous close. A number of other […]

Related Keywords

United States ,Canada ,America ,Stifel Nicolaus ,Craig Hallum ,Royal Bank ,Hanseatic Management Services Inc ,Keycorp ,Advisors Inc ,Fortis Capital Advisors ,Repligen Corp ,Whittier Trust Co ,Get Rating ,Management Services ,Capital Advisors ,Allworth Financial ,Asia Pacific Region ,Repligen Daily ,Repligen ,Nasdaq Rgen ,Rgen ,Medical ,75991610 ,Lower Price Target ,Royal Bank Of Canada ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.